| 8076298 |
Treating acute renal failure with soluble thrombomodulin variants |
Bryan Edward Jones, Bruce A. Molitoris |
2011-12-13 |
$77,945,000 |
| 7638123 |
Methods of treating diseases with activated protein C |
Angelina Vucic Ciaccia, Lawrence Mark Gelbert, Bryan Edward Jones, David Eugene Joyce |
2009-12-29 |
$226,829,000 |
| 7204981 |
Methods of treating diseases with activated protein C |
Angelina Vucic Ciaccia, Lawrence Mark Gelbert, Bryan Edward Jones, David Eugene Joyce |
2007-04-17 |
$53,357,000 |
| 6630138 |
Protein C derivatives |
Bruce Gerlitz, Bryan Edward Jones |
2003-10-07 |
$109,475,000 |
| 6545027 |
Methods of modulating NF-kB transcription factor |
David Thompson Berg, David S. Calnek |
2003-04-08 |
$238,604,000 |
| 6489296 |
Method of reducing mortality in severe sepsis |
Daniel Hartman, Sau-Chi Betty Yan |
2002-12-03 |
$274,502,000 |
| 6426071 |
Methods for treating vascular disorders |
Daniel C Howey, Charles Van Jackson |
2002-07-30 |
$189,967,000 |
| RE37806 |
Method of using eukaryotic expression vectors comprising the BK virus enhancer |
— |
2002-07-23 |
|
| RE37720 |
Method of using eukaryotic expression vectors comprising the BK virus enhancer |
— |
2002-05-28 |
|
| 6268344 |
Methods for treating hypercoagulable states or acquired protein C deficiency |
Daniel Hartman, Sau-Chi Betty Yan |
2001-07-31 |
$161,665,000 |
| 6268337 |
Methods for treating vascular disorders using activated protein C |
Daniel C Howey, Charles Van Jackson |
2001-07-31 |
$161,665,000 |
| 6242192 |
Method of using eukaryotic expression vectors comprising the bk virus enhancer |
— |
2001-06-05 |
$240,697,000 |
| 6156734 |
Methods for treating hypercoagulable states or acquired protein C deficiency |
Daniel Hartman, Sau-Chi Betty Yan |
2000-12-05 |
$334,564,000 |
| 6071514 |
Methods for treating thrombotic disorders |
Joseph A. Jakubowski |
2000-06-06 |
$207,732,000 |
| 6057130 |
Method of using eukaryotic expression vectors comprising the BK virus enhancer |
— |
2000-05-02 |
$430,547,000 |
| 6037322 |
Methods for treating vascular disorders using activated protein C |
Daniel C Howey, Charles Van Jackson |
2000-03-14 |
$155,159,000 |
| 6008199 |
Methods for treating hypercoagulable states or acquired protein C deficiency |
Daniel Hartman, Sau-Chi Betty Yan |
1999-12-28 |
$78,907,000 |
| 5980938 |
Effect of compounds that suppress induction of plasminogen activator inhibitor 1 (PAI-1) |
David Thompson Berg, George J. Cullinan, Mark A. Richardson |
1999-11-09 |
$103,079,000 |
| 5962698 |
Benzothiophene compounds, and uses and formulations thereof |
David Thompson Berg, George J. Cullinan, Mark A. Richardson |
1999-10-05 |
$103,905,000 |
| 5948795 |
Benzothiopene compounds, and uses and formulations thereof |
David Thompson Berg, George J. Cullinan, Mark A. Richardson |
1999-09-07 |
$158,841,000 |
| 5879919 |
Method of using eukaryotic expression vectors comprising the BK virus enhancer |
— |
1999-03-09 |
$255,027,000 |
| 5858704 |
Method of using eukaryotic expression vectors comprising the BK virus enhancer |
— |
1999-01-12 |
$254,802,000 |
| 5792798 |
Method for inhibiting plasminogen activator inhibitor 1 |
David Thompson Berg, George J. Cullinan, Mark A. Richardson |
1998-08-11 |
$117,173,000 |
| 5780648 |
Benzothiophene compounds, and uses formulations thereof |
David Thompson Berg, George J. Cullinan, Mark A. Richardson |
1998-07-14 |
$166,141,000 |
| 5770397 |
Method of using eukaryotic expression vectors comprising the BK virus enhancer |
— |
1998-06-23 |
$129,130,000 |
